New Mexico’s Medical Advisory Board voted 5 to 1 to recommend medical cannabis for “opiate use disorder” and Alzheimer’s disease.
The board also voted to allow medical cannabis to be recommend via telemedicine. This includes physicians meeting with patients through Skype and other online programs. The recommendations go to the Department of Health which has the final say on whether to accept them.
Officials believe that there are roughly 33,000 people in New Mexico with opiate use disorder. This is a huge increase from just a year ago, when the number was around 18,000.
The board also stated that the number of plants patients are allowed to cultivate should be increased.
“It’s your duty to ensure that adequate supply is maintained,” said one of the board’s member, noting that an appropriate cap would be around 230 grams per patient per quarter, much higher than the current cap of 36 grams..
The board’s approval of this measures were met with applause from the audience.